Mechanism of noradrenaline-induced heterologous desensitization of adenylate cyclase stimulation in rat heart muscle cells: increase in the level of inhibitory G-protein alpha-subunits

European Journal of Pharmacology
C ReithmannK H Jakobs

Abstract

The mechanism of heterologous desensitization of adenylate cyclase stimulation was studied in cultured neonatal rat heart muscle cells. After culturing of the cells for 3 days in the presence of 1 microM noradrenaline there was in addition to a 52% decrease in isoproterenol-stimulated adenylate cyclase activity, a lessening of the stimulation of beta-adrenoceptor-independent adenylate cyclase by guanosine-5'-O-(thiotriphosphate) and forskolin by 24 and 34%, respectively. The decrease in receptor-independent adenylate cyclase stimulation by forskolin, but not the attenuation of isoproterenol-stimulated adenylate cyclase activity, was abolished by pertussis toxin (PTX) pretreatment of the cells. Gi, the inhibitory G-protein of adenylate cyclase was therefore quantitated. Labelling of the Mr approximately 40 kDa PTX substrates in membranes of noradrenaline-treated cells was increased by 70% as shown by pertussis toxin-catalyzed ADP ribosylation of heart cell membranes. This increase was also seen in the presence of an excess of purified beta gamma-subunits of transducin and of GTP, suggesting that the increased labelling was not due to elevation of the level of beta gamma-subunits or increase in the concentration of GTP in the mem...Continue Reading

References

Jun 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D Cassel, T Pfeuffer
Jul 1, 1988·The Journal of Clinical Investigation·A M FeldmanC Van Dop
Sep 1, 1988·European Journal of Pharmacology·C Reithmann, K Werdan
Jan 1, 1985·Methods in Enzymology·F A Ribeiro-NetoR D Sekura
Jul 1, 1985·Journal of Molecular and Cellular Cardiology·M R BristowM B Fowler
Oct 22, 1988·Lancet·J NeumannP Kalmar
Jan 1, 1987·Annual Review of Biochemistry·A G Gilman

❮ Previous
Next ❯

Citations

Jan 1, 1996·Basic Research in Cardiology·T EschenhagenL S Weinstein
Jun 1, 1991·Cardiovascular Drugs and Therapy·A J Kaumann
Jun 22, 1993·Biochemical Pharmacology·M D Johnson, E Friedman
Sep 15, 1994·Biochemical Pharmacology·G MilliganC M Brown
Nov 13, 1992·European Journal of Pharmacology·S E HardingP A Poole-Wilson
Aug 29, 1996·European Journal of Pharmacology·D G WynneS E Harding
Dec 31, 1997·The American Journal of Cardiology·M R Bristow
Apr 25, 2000·Brain Research. Developmental Brain Research·J L ZeidersT A Slotkin
Oct 8, 1997·Journal of the American College of Cardiology·M BöhmA Stäblein
Jun 1, 1997·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·S A Sands, B M Chronwall
Feb 12, 1998·Thyroid : Official Journal of the American Thyroid Association·G J JuvenalM A Pisarev
Jun 3, 2005·Thyroid : Official Journal of the American Thyroid Association·P A NosedaG J Juvenal
Jan 1, 1990·British Journal of Clinical Pharmacology·C ReithmannK H Jakobs
Mar 1, 1993·British Journal of Pharmacology·M C Butterfield, R Chess-Williams
Apr 1, 1993·British Heart Journal·J A HallM J Brown
Jun 27, 2006·Journal of Pharmacological Sciences·Yasuko IshikawaHajime Ishida
Nov 1, 1995·Hypertension·R D FeldmanJ Chorazyczewski
May 20, 1999·Circulation·V J OwenS E Harding

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.